Lyndon Wright

1.7k total citations
49 papers, 1.4k citations indexed

About

Lyndon Wright is a scholar working on Psychiatry and Mental health, Neurology and Biochemistry. According to data from OpenAlex, Lyndon Wright has authored 49 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Psychiatry and Mental health, 10 papers in Neurology and 10 papers in Biochemistry. Recurrent topics in Lyndon Wright's work include Parkinson's Disease Mechanisms and Treatments (10 papers), Eicosanoids and Hypertension Pharmacology (9 papers) and Hormonal Regulation and Hypertension (8 papers). Lyndon Wright is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (10 papers), Eicosanoids and Hypertension Pharmacology (9 papers) and Hormonal Regulation and Hypertension (8 papers). Lyndon Wright collaborates with scholars based in Portugal, United Kingdom and Singapore. Lyndon Wright's co-authors include Patrício Soares‐da‐Silva, Ana I. Loureiro, Luís Almeida, Amílcar Falcão, Teresa Nunes, Carlos Fernandes‐Lopes, Maria João Bonifácio, Manuel Vaz‐da‐Silva, José‐Francisco Rocha and Amílcar Soares and has published in prestigious journals such as Journal of Biological Chemistry, The FASEB Journal and Hypertension.

In The Last Decade

Lyndon Wright

47 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lyndon Wright Portugal 19 420 372 276 260 235 49 1.4k
Ana I. Loureiro Portugal 21 394 0.9× 383 1.0× 244 0.9× 187 0.7× 340 1.4× 60 1.6k
José‐Francisco Rocha Portugal 17 190 0.5× 308 0.8× 680 2.5× 135 0.5× 286 1.2× 49 1.3k
Seema Briyal United States 23 287 0.7× 81 0.2× 106 0.4× 339 1.3× 61 0.3× 45 1.2k
Yisong Qian China 24 709 1.7× 144 0.4× 52 0.2× 192 0.7× 23 0.1× 50 1.5k
Carlos Fernandes‐Lopes Portugal 11 217 0.5× 367 1.0× 29 0.1× 153 0.6× 40 0.2× 24 754
Dalaal M. Abdallah Egypt 22 523 1.2× 28 0.1× 128 0.5× 221 0.8× 47 0.2× 75 1.6k
Tharusha Jayasena Australia 16 302 0.7× 288 0.8× 46 0.2× 328 1.3× 45 0.2× 22 1.0k
Qidi Ai China 24 795 1.9× 41 0.1× 63 0.2× 125 0.5× 36 0.2× 59 1.6k

Countries citing papers authored by Lyndon Wright

Since Specialization
Citations

This map shows the geographic impact of Lyndon Wright's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lyndon Wright with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lyndon Wright more than expected).

Fields of papers citing papers by Lyndon Wright

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lyndon Wright. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lyndon Wright. The network helps show where Lyndon Wright may publish in the future.

Co-authorship network of co-authors of Lyndon Wright

This figure shows the co-authorship network connecting the top 25 collaborators of Lyndon Wright. A scholar is included among the top collaborators of Lyndon Wright based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lyndon Wright. Lyndon Wright is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hickert, Sebastian, Joerg Schlingemann, A Adams, et al.. (2024). Escaping the cohort of concern: in vitro experimental evidence supports non-mutagenicity of N-nitroso-hydrochlorothiazide. Archives of Toxicology. 98(12). 4159–4172. 5 indexed citations
2.
3.
Bonifácio, Maria João, Marco A. C. Neves, P. Nuno Palma, et al.. (2015). Characterization of the interaction of the novel antihypertensive etamicastat with human dopamine-β-hydroxylase: Comparison with nepicastat. European Journal of Pharmacology. 751. 50–58. 9 indexed citations
4.
Rocha, José‐Francisco, Amílcar Falcão, A. Santos, et al.. (2014). Effect of opicapone and entacapone upon levodopa pharmacokinetics during three daily levodopa administrations. European Journal of Clinical Pharmacology. 70(9). 1059–1071. 49 indexed citations
5.
Pires, Nuno, Maria João Bonifácio, Ana I. Loureiro, et al.. (2014). Blood pressure-decreasing effect of etamicastat alone and in combination with antihypertensive drugs in the spontaneously hypertensive rat. Hypertension Research. 38(1). 30–38. 22 indexed citations
6.
7.
Loureiro, Ana I., Carlos Fernandes‐Lopes, Maria João Bonifácio, Lyndon Wright, & Patrício Soares‐da‐Silva. (2013). N-Acetylation of Etamicastat, a Reversible Dopamine-β-Hydroxylase Inhibitor. Drug Metabolism and Disposition. 41(12). 2081–2086. 18 indexed citations
8.
Almeida, Luís, José Rocha, Amílcar Falcão, et al.. (2012). Pharmacokinetics, Pharmacodynamics and Tolerability of Opicapone, a Novel Catechol-O-Methyltransferase Inhibitor, in Healthy Subjects. Clinical Pharmacokinetics. 52(2). 139–151. 69 indexed citations
9.
Loureiro, Ana I., Carlos Fernandes‐Lopes, Lyndon Wright, & Patrício Soares‐da‐Silva. (2011). Development and validation of an enantioselective liquid-chromatography/tandem mass spectrometry method for the separation and quantification of eslicarbazepine acetate, eslicarbazepine, R-licarbazepine and oxcarbazepine in human plasma. Journal of Chromatography B. 879(25). 2611–2618. 21 indexed citations
10.
Nunes, Teresa, José Rocha, Manuel Vaz‐da‐Silva, et al.. (2010). Safety, Tolerability, and Pharmacokinetics of Etamicastat, a Novel Dopamine-β-Hydroxylase Inhibitor, in a Rising Multiple-Dose Study in Young Healthy Subjects. Drugs in R&D. 10(4). 225–242. 21 indexed citations
11.
Wright, Lyndon, Joana Maia, Ana I. Loureiro, Luís Almeida, & Patrício Soares‐da‐Silva. (2010). Pharmacokinetics, Disposition, and Metabolism of [14C]-Nebicapone in Humans. Drug Metabolism Letters. 4(3). 149–162. 3 indexed citations
12.
13.
Almeida, Luís, Manuel Vaz‐da‐Silva, Amílcar Falcão, et al.. (2009). Pharmacokinetic and safety profile oftrans‐resveratrol in a rising multiple‐dose study in healthy volunteers. Molecular Nutrition & Food Research. 53(S1). S7–15. 369 indexed citations
14.
Nunes, Teresa, Luís Almeida, José‐Francisco Rocha, et al.. (2009). Pharmacokinetics of Trans‐resveratrol Following Repeated Administration in Healthy Elderly and Young Subjects. The Journal of Clinical Pharmacology. 49(12). 1477–1482. 89 indexed citations
15.
Vaz‐da‐Silva, Manuel, Ana I. Loureiro, Teresa Nunes, et al.. (2008). Pharmacokinetic-Pharmacodynamic Interaction between Nebicapone, a Novel Catechol-O-Methyltransferase Inhibitor, and Controlled-Release Levodopa/Carbidopa 200 mg/50 mg. Drugs in R&D. 9(6). 435–446. 4 indexed citations
16.
Ferreira, Joaquim J., Luís Almeida, Luı́s Cunha, et al.. (2008). Effects of Nebicapone on Levodopa Pharmacokinetics, Catechol-O-methyltransferase Activity, and Motor Fluctuations in Patients with Parkinson Disease. Clinical Neuropharmacology. 31(1). 2–18. 26 indexed citations
17.
Loureiro, Ana I., Maria João Bonifácio, Carlos Fernandes‐Lopes, et al.. (2006). Human Metabolism of Nebicapone (BIA 3-202), a Novel Catechol-O-Methyltransferase Inhibitor: Characterization of in Vitro Glucuronidation. Drug Metabolism and Disposition. 34(11). 1856–1862. 21 indexed citations
18.
Almeida, Luís, Manuel Vaz‐da‐Silva, Amílcar Falcão, et al.. (2004). Pharmacokinetic–Pharmacodynamic Interaction Between BIA 3-202, a Novel COMT Inhibitor, and Levodopa/Carbidopa. Clinical Neuropharmacology. 27(1). 17–24. 14 indexed citations
19.
Palma, P. Nuno, Maria João Bonifácio, Ana I. Loureiro, et al.. (2003). Molecular Modeling and Metabolic Studies of The Interaction of Catechol-O-Methyltransferase and a New Nitrocatechol Inhibitor. Drug Metabolism and Disposition. 31(3). 250–258. 37 indexed citations
20.
Wilson, Robert C., et al.. (1989). Bioavailability of gentamicin in dogs after intramuscular or subcutaneous injections. American Journal of Veterinary Research. 50(10). 1748–1750. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ana I. Loureiro Breakdown of academic impact, for papers by José‐Francisco Rocha Breakdown of academic impact, for papers by Seema Briyal Breakdown of academic impact, for papers by Yisong Qian Breakdown of academic impact, for papers by Carlos Fernandes‐Lopes Breakdown of academic impact, for papers by Dalaal M. Abdallah Breakdown of academic impact, for papers by Tharusha Jayasena Breakdown of academic impact, for papers by Qidi Ai
Rankless by CCL
2026